| |
| |
|
| Insider
Information: |
Parini Michael |
| Relationship: |
EVP, Chief Adm, Leg & ... |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
30,837 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,895,504 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
30,837 |
|
|
| Total
Value |
$14,895,504 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Chief Adm, Leg & ... |
2021-02-25 |
30,837 |
2016-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
115 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-04-25 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
42,123 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-07-12 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
41,734 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-07-12 |
4 |
AS |
$175.02 |
$371,918 |
D/D |
(2,125) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-10-12 |
4 |
AS |
$177.20 |
$376,550 |
D/D |
(2,125) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-10-12 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
41,734 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-01-14 |
4 |
AS |
$186.71 |
$396,759 |
D/D |
(2,125) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-01-14 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
41,734 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-07-12 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
37,128 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-07-12 |
4 |
AS |
$175.09 |
$372,455 |
D/D |
(2,125) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-10-14 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
37,128 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-10-14 |
4 |
AS |
$173.44 |
$369,885 |
D/D |
(2,125) |
35,003 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2020-04-29 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
28,963 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2020-04-29 |
4 |
AS |
$251.38 |
$541,769 |
D/D |
(2,125) |
26,838 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2020-07-13 |
4 |
OE |
$90.29 |
$191,866 |
D/D |
2,125 |
28,963 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Adm, Leg & BD Off |
• – – |
2020-07-13 |
4 |
AS |
$284.28 |
$620,610 |
D/D |
(2,125) |
26,838 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2019-05-03 |
4 |
OE |
$86.52 |
$201,505 |
D/D |
2,329 |
37,332 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-08-03 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
31,139 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-08-03 |
4 |
AS |
$155.72 |
$362,828 |
D/D |
(2,330) |
28,809 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-11-03 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
31,139 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2017-11-03 |
4 |
AS |
$149.50 |
$348,335 |
D/D |
(2,330) |
28,809 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-02-05 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
27,823 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-02-05 |
4 |
AS |
$163.08 |
$379,976 |
D/D |
(2,330) |
25,493 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-05-03 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
41,939 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-05-03 |
4 |
AS |
$149.50 |
$348,335 |
D/D |
(2,330) |
39,609 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, CL&AO |
• – – |
2018-08-03 |
4 |
OE |
$86.52 |
$201,592 |
D/D |
2,330 |
41,939 |
0 |
- |
|
115 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
